TTK Healthcare Ltd. (BSE: 507747) is a Chennai, Tamil Nadu-based company in the Sexual Wellness Products industry. With a market capitalisation of ₹1,291 Cr, it ranks #1,427 by market cap among the 6,197 Indian listed companies on FinBizNet, and #2 of 3 in Sexual Wellness Products. At ₹925.50 (as of 10 Nov 2026), the share price is 25.8% below its 52-week high of ₹1,247.00 and 25.9% above its 52-week low of ₹735.00. The share price is down 21.3% over one year and down 12.6% over three months.
| Current Price | ₹925.50 |
|---|---|
| Market Cap | ₹1,291 Cr |
| BSE Code | 507747 |
| Sector | Consumer Staples > Household and Personal Products > Personal Care Products |
| Sub-Industry | Personal Care Products > Sexual Wellness Products |
| P/E Ratio | 19.7 |
| Return on Equity | 6.03% |
| Return on Assets | 0.83% |
| 52-Week Range | ₹735.00 – ₹1,247.00 |
| 1-Year Price Change | -21.3% |
| 3-Month Price Change | -12.6% |
| Beta (1Y) | 0.46 |
| Dividend Yield | 1.09% |
| Headquarters | Chennai, Tamil Nadu |
| Website | www.ttkhealthcare.com |
| Revenue | ₹233 Cr |
|---|---|
| Net Profit | ₹223 Cr |
| Net Margin | 95.5% |
| EPS (Basic) | ₹157.80 |
| Basis | standalone |
Figures in ₹ crore, parsed from the company's exchange filing (XBRL).
TTK Healthcare Ltd. reported revenue of ₹233 Cr in Q2 FY27, up 14.6% from ₹204 Cr in Q2 FY26 and down 9.4% from ₹258 Cr in Q1 FY27. It posted a net profit of ₹223 Cr for the quarter, against a net profit of ₹20 Cr in Q2 FY26 (up 993.5%). Across the 7 quarters from Q4 FY25 to Q2 FY27, quarterly revenue ranged from ₹190 Cr (Q4 FY25) to ₹258 Cr (Q1 FY27). The company was profitable in each of these 7 quarters.
| Quarter | Revenue | Net Profit | Net Margin |
|---|---|---|---|
| Q2 FY27 | ₹233 Cr | ₹223 Cr | 95.5% |
| Q1 FY27 | ₹258 Cr | ₹21 Cr | 8.3% |
| Q4 FY26 | ₹218 Cr | ₹22 Cr | 10.0% |
| Q3 FY26 | ₹209 Cr | ₹11 Cr | 5.0% |
| Q2 FY26 | ₹204 Cr | ₹20 Cr | 10.0% |
| Q1 FY26 | ₹226 Cr | ₹13 Cr | 5.7% |
| Q4 FY25 | ₹190 Cr | ₹16 Cr | 8.5% |
Standalone figures (₹ crore, XBRL filings).
Promoters held 74.56% of TTK Healthcare Ltd.'s shares as of Sept 2026, unchanged from Sept 2025. Delivery averaged 53.6% of traded volume across 16 NSE sessions (15 Oct 2026 – 9 Nov 2026).
TTK Healthcare Limited engages in the animal welfare, consumer product, medical device, protective device, food, and other businesses in India. It operates through Animal Welfare, Consumer Products, Medical Devices, Protective Devices, Foods, and Others segments. The Animal Welfare segment offers various feed supplements, liver correctives, fertility inducers, antibiotics, antiparasiticides, antispasmodics, cervical dilators, cocktail enzymes, etc. to veterinarians, dairy, poultry and aqua farmers, and pet parents. The Consumer Products segment is involved in the marketing and distribution of baby care products under the Woodward's Gripe water name; personal care products and cosmetics under the EVA name; home care products, such as scrubbers under the Good Home name; and air fresheners. The Medical Devices segment manufactures and markets artificial heart valves under the TTK Chitra name, as well as orthopedic implants and instruments for knee and hip replacements. The Protective Devi
1. Animal Welfare Division-This segment provides products for veterinary use. 2. Consumer Products-This segment engages in the marketing and distribution of Gripewater, EVA range of cosmetics, Good Home range of scrubbers, air fresheners, etc. 3. Medical Devices-This segment offers artificial heart valves, orthopaedic implants, etc. 4. Protective Devices-This segment manufactures and markets male contraceptives and other allied products.
1. Animal Welfare-16.5% 2. Consumer Products-28.1% 3. Medical Devices-12.5% 4. Protective Devices-25.3% 5. Foods-17.6% 6. Others-0%
| Company | Market Cap | P/E | ROE | Latest Qtr Revenue | 1Y Change |
|---|---|---|---|---|---|
| Cupid Ltd. | ₹45,752 Cr | 430.7 | 27.30% | ₹155 Cr | +601.8% |
| TTK Healthcare Ltd. | ₹1,291 Cr | 19.7 | 6.03% | ₹233 Cr | -21.3% |
| Rajnish Wellness Ltd | ₹37 Cr | n/m | -6.73% | — | -54.2% |
Listed by market capitalisation. Ratios are shown for context only.
TTK Healthcare Ltd. is trading at ₹925.50, with a market capitalisation of ₹1,291 Cr.
TTK Healthcare Ltd. operates in the Consumer Staples > Household and Personal Products > Personal Care Products space (Personal Care Products > Sexual Wellness Products).
TTK Healthcare Ltd. has a P/E of 19.7 and a return on equity of 6.03%.
TTK Healthcare Ltd. is listed on the BSE under the scrip code 507747.
TTK Healthcare Ltd.'s share price is down 21.3% over one year and down 12.6% over three months. Its 52-week range is ₹735.00 to ₹1,247.00.
In Q2 FY27, TTK Healthcare Ltd. reported revenue of ₹233 Cr and net profit of ₹223 Cr, with basic EPS of ₹157.8 (standalone, parsed from the company's exchange filing).
TTK Healthcare Ltd. reported revenue of ₹233 Cr in Q2 FY27, up 14.6% from ₹204 Cr in Q2 FY26 and down 9.4% from ₹258 Cr in Q1 FY27.
Promoters held 74.56% of TTK Healthcare Ltd.'s shares as of Sept 2026, unchanged from Sept 2025.
Data as of 10 Nov 2026. Descriptive market data only — not investment advice.